0 items USD 0.00Search
Your search for "datagroup lessors miscellaneous nonresidential buildings lines world report" gave back 87 results.
Global injectable drugs market will reach $1,037.7 billion by 2030, growing by 9.8% annually over 2020-2030 driven by the increasing prevalence of...
Catalog:
Grace Market Data
November 2021
Price: USD 2,900.00
Indian pharma retail market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions...
Catalog:
NAVADHI
June 2019
Price: USD 1,100.00
Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital...
Catalog:
iGATE
July 2017
Price: USD 1,890.00
Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing Summary GBI Research’s latest report,"...
Catalog:
CBR Pharma Insights
January 2017
Price: USD 2,995.00
Indian pharma retail market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions...
Catalog:
NAVADHI
June 2019
Price: USD 1,000.00
India is expected to witness a remarkable rise in healthcare infrastructure in upcoming years. There will there be a dramatic rise in the type and...
Catalog:
NAVADHI
June 2019
Price: USD 1,000.00
Pharmacy Benefit Managers are under pressure: The industry is a lightning rod for America’s healthcare system at its worst Summary By 2019, the...
Catalog:
MarketLine
February 2019
Price: USD 995.00
The United States market for pain management therapeutics remains a substantial growth area for pharmaceutical companies, as they continue their...
Catalog:
iGATE
September 2017
Price: USD 1,100.00
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies Summary GBI Research’s...
CBR Pharma Insights
February 2018
Price: USD 2,995.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products...
Catalog:
CBR Pharma Insights
January 2018
Price: USD 2,995.00
Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design Summary GBI...
CBR Pharma Insights
March 2017
Price: USD 2,995.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
